Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis (Q30408691)

21 June 2017

1 reference

1 reference

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis (English)

1 reference

21 June 2017

0 references

1 reference

1 reference

4

Edward A Belongia

1 reference

21 June 2017

1

Michael T Osterholm

1 reference

21 June 2017

N. S. Kelley

2

Nicholas S Kelley

1 reference

21 June 2017

A. Sommer

series ordinal

3

object named as

Alfred Sommer

1 reference

21 June 2017

language of work or name

1 reference

25 October 2011

1 reference

Lancet Infectious Diseases

21 June 2017

published in

1 reference

21 June 2017

volume

12

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

36-44

1 reference

Current knowledge of influenza vaccine

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza immunization: Statement

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Diagnostic methods in an influenza vaccine trial.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Estimating influenza vaccine efficacy from challenge and community-based study data

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Comparative efficacy of inactivated and live attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Impact of influenza vaccination on seasonal mortality in the US elderly population.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Confounding by season in ecologic studies of seasonal exposures and outcomes: examples from estimates of mortality due to influenza

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccination and mortality benefits: new insights, new opportunities

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Evidence of bias in studies of influenza vaccine effectiveness in elderly patients.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza vaccination and mortality: differentiating vaccine effects from bias

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Influenza Vaccines for the Future

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70295-X

7 January 2021

10.1016/S1473-3099(11)70295-X

Identifiers

DOI

1 reference

21 June 2017

1 reference